Abstract
The process of proliferation, invasion and metastasis is a complex one which involves both the autonomy of the malignant cells and their interaction with the cellular and extracellular environments. The way in which the tumor cells respond to cellular and extracellular stimuli is regulated through transduction of those signals and translation into cellular activity. Transmembrane signal transduction involves three major categories of events: ion channel activation, transmission through guanine nucleotide binding protein intermediates with production of second messengers, and phosphorylation events. A frequent common denominator of these different pathways is a cellular calcium homeostasis. Calcium may be both a result of and a regulator of many of these signal transduction pathways and has been shown to have a role in the regulation of proliferation, invasion, and metastatic potential. The understanding and application of the basic tenets of these pathways to tumor cell proliferation, invasion, and metastases opens a new target for therapeutic intervention. We have identified a novel agent, CAI, which through inhibition of stimulated calcium influx inhibits proliferation and migrationin vitro, and growth and dissemination in human cancer xenograftsin vivo. CAI offers a new approach to cancer therapy, signal transduction therapy.
Similar content being viewed by others
Abbreviations
- G protein:
-
Guanine nucleotide binding protein
- CAI:
-
Carboxyamido-triazole
- EGF:
-
Epidermal Growth Factor
References
Cancer statistics. CA Journal 43: 1–19, 1993
Reeve JG: Mitogenesis and the search for new targets for anticancer drug design. Tumor Biol 12: 1–8, 1991
Moffet AS: Going back to the future with small synthetic compounds. Science 260: 910–912, 1993
Spiegel AM: G proteins in clinical medicine. Hosp Practice, June 15: 1988
Tang WJ, Gilman AG: Adenylyl cyclases. Cell 70: 869–872, 1992
Freissmuth M, Casey PJ, Gilman AG: G proteins control diverse pathways of transmembrane signaling. FASEB J 3: 2125–2131, 1989
Rosenthal W, Hescheler J, Trautwein W, Schultz G: Control of voltage-dependent Ca2+ by G protein-coupled receptors. FASEB J 2: 2784–2790, 1988
Neer EJ, Clapham DE: Roles of G protein subunits in transmembrane signalling. Nature 333: 129–134, 1988
Simon MI, Strathmann MP, Gautam N: Diversity of G proteins in signal transduction. Science 252: 802–808, 1991
Conklin BR, Bourne HR: Structural elements of Gα subunits that interact with Gβγreceptors, and effectors. Cell 73: 631–641, 1993
Aaronson SA: Growth factors and cancer. Science 254: 1146–1153, 1991
Pelech SL, Sanghera: MAP kinases: charting the regulatory pathways. Science 257: 1355–1356, 1992
Lin LL, Wartmann M, Lin AY, Knopt JL, Seth A, davis RJ: cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278, 1993
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD: Molecular biology of the cell. Second edition. Garland Publishing Inc., NY: 706–708, 1989
Tanaguchi T, Kitagawea H, Yasua S,et al. Protein-tyrosine kinase p72syk is activated by thrombin and is negatively regulated through Ca2+ regulation in platelets. J Biol Chem 268: 2277–2279, 1993
Rhee SG, Suh P-G, Ryu S-H, Lee SY: Studies of inositol phospholipid-specific phospholipase C. Science 244: 546–550, 1989
Neher E: Ion channel for communication between and within cells. Science 256: 498–502, 1992
Brown AM, Birnbaumer L: Ionic channels and their regulation by G protein subunits. Annu Rev Physiol 52: 197–213, 1990
Rink TJ: Receptor-mediated calcium entry. FEBS Lett 268: 381–385, 1990
Meldolesi J, Clementi E, Fusolato C, Zacchetti D, Pozzan T. Ca2+ influx following receptor activation. Trends Pharmacol Sci 12: 289–292, 1991
Berridge M: Inositol triphosphate and diacylglycerol: two interacting second messengers. Ann Rev Biochem 56: 159–193, 1987
Irvine RF: Inositol phosphates and Ca2+ entry: toward a proliferation or a simplification. FASEB J 6: 3085–3091, 1992
Berridge MJ, Irvine RF: Inositol phosphates and cell signalling. Nature 341: 197–205, 1989
Klee CB: Ca++ dependent phospholipid (and membrane) binding proteins. Biochemistry 27: 6645–6653, 1988
Bell RM: Protein kinase C activation by diacylglycerol second messengers. Cell 45: 631–632, 1986
Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575–5589, 1992
Julius D, Livelli TJ, Jessell TM, Axel R: Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244: 1057–1061, 1989
Allen LF, Lefkowitz RJ, Caron MG, Cotecchia S: G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the α1-B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA 88: 11354–11358, 1991
Gutkind JS, Novotny EA, Brann MR, Robbins KC: Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci USA 88: 4703–4707, 1991
Felder CC, Dieter P, Kinsella J, Tamura K, Kanterman RY, Axelrod J: A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C. J Pharm Exp Ther 255: 1140–1147, 1990
Felder CC, Poulter MO, Wess J: Muscarinic receptor-operated CA2+ influx in transfected fibroblast cell is independent of inositol phosphates and release of intracellular Ca2+. Proc Natl Acad Sci USA 89: 509–213, 1992
Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutation activates the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692–696, 1989
Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh Q-Y, Clark OH, Kawasaki E, Bourne HR, McCormick F: Two G protein oncogenes in human endocrine tumors. Science 250: 655–659, 1990
Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S: Oncogenes and signal transduction. Cell 64: 281–302, 1991
Fleischman LF, Chawala SB, Cantley L: Ras-transformed cells: Altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites. Science 231: 407–410, 1986
Sethi T, Langdon S, Smyth J, Rozengurt E: Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonistsin vitro andin vivo. Cancer Res 52: 2737s-2742s, 1992
Moody TW, Cuttitta F: Growth factor and peptide receptors in small cell lung cancer. Life Sciences 52: 1161–1173, 1993
Imoto M, Sujikai I, Hideaki U, Umezawa K: Involvement of tyrosine kinase in growth factor-induced phospholipase C activation in NIH3T3 cells. Biochim Biophys Acta: 188-172, 1993
Kohn EC, Liotta LA: Invasion and metastasis: new approaches to an old problem. Oncology 7: 47–62, 1993
Liotta LA: Tumor invasion and metastases: role of the extracellular matrix. Rhoads memorial award lecture. Cancer Res 46: 1–7, 1986
Zabrenetzsky V, Gallin EK: Inositol 1,4,5-trisphosphate concentrations increase after adherence in the macrophagelike cell line J 774.1. Biochem J 255: 1037–1043, 1988
Aznavoorian S, Stracke ML, Krutzsch H, Schiffmann E, Liotta LA: Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 110: 1427–1438, 1990
McCarthy JB, Hagen ST, Furcht LT: Human fibronectin contains distinct adhesion and motility promoting domains for metastatic melanoma cells. J Cell Biol 102: 179–188, 1986
Yamada KM: Cell surface interactions with extracellular materials. Annu Rev Biochem 52: 761–799, 1983
Brown PD, Levy AT, Margulies IMK, Liotta LA, Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184–6191, 1990
Stetler-Stevenson WG, Krutzsch HC, Wacher MPet al.: The activation of human type IV collagenase proenzyme. J Biol Chem 264: 1353–1356, 1989
Kerr LD, Miller DB, Matrisian L: TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 61: 267–278, 1990
Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA: Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267: 2524–2529, 1992
Stracke ML, Guirguis R, Liotta LA, Schiffmann E: Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. Biochem Biophys Res Commun 146: 339–345, 1987
Liotta LA, Mandler R, Murano G: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302–3306, 1986
Kohn EC, Liotta LA, Schiffman E: Autocrine motility factor stimulates a three-fold increase in inositol trophosphate in human melanoma cells. Biochem Biophys Res Commun 166: 757–764, 1990
Evans CP, Walsh DS, Kohn EC: An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1. Int J Cancer 49: 109–113, 1991
Savarese DMF, Russel JT, Fatatis A, Liotta LA: Type IV collagen stimulates an increase in intracellular calcium: potential role in tumor cell motility. J Biol Chem 267: 21928–21935, 1992
Zabrenetzsky V, Roberts DD: Signal transduction during thrombospondin-stimulated motility of A2058 human melanoma cells. Proc Am Assoc Cancer Res 34: 33, 1993
Minniti CP, Kohn EC, Grubb JH, Sly WS, Oh Y, Muller HL, Rosenfeld RG, Helman LJ: The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II induced motility in human rhabdomyosarcoma cells. J Biol Chem 267: 9000–9004, 1992
Cross M, Exeter MT: Growth factors in development, transformation, tumorigenesis. Cell 64: 271–280, 1991
Egan SE, McClarty GA, Jarolin L, Wright JA, Spiro I, Hager C, Greenberg AH: Expression of H-ras correlates with metastatic potential phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7: 830–837, 1987
Folkman J, Shing Y: Angiogenesis. J Biol Chem 267: 10931–10934, 1992
Hauang AJ, Manning JE, Banbak TM, Ratau MC, Hanser KR, Silverstein SC: Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 120: 1371–1380, 1993
Marks PW, Maxfield FR: Transient increases in cytosolic free calcium appears to be required for the migration of adherent human neutrophils. J Cell Biol 110: 43–52, 1990
Mamachi T, Hirata M, Koga T: Origin of intracellular calcium and quantitation of mobilizable calcium in neutrophils stimulated with chemotactic peptide. Biochem Biophys Acta 889: 136–148, 1986
Kohn EC, Francis EA, Liotta LA, Schiffmann E: Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells. Int J Cancer 46: 287–292, 1990
Lester BR, Weinstein LS, McCarthy JB, Sun Z, Smith RS, Furcht LT: The role of G-proteins in matrix-mediated motility of highly and poorly invasive melanoma cells. Int J Cancer 48: 113–120, 1991
Lester BR, McCarthy JB, Sun Z, Smith RS, Furcht LT, Spiegel AM: G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 Melanoma clones. Cancer Res 49: 5940–5948, 1989
Zachary JM, Cleveland G, Kwoch L, Lawrance T, Weissman RM, Nabell L, Fried FA, Staab EV, Risinger MA, Lin S: Actin filament organization of the dunning R3327 rat prostatic adenocarcinoma system: correlation with metastatic potential. Cancer Res 46: 926–932, 1986
Sheth B, Banks P, Burton DR, Monk PN: The regulation of actin polymeration in differentiating U937 cells correlated with increased membrane levels of the pertussis-toxin-sensitive G-protein Gi2. Biochem J 275: 809–811, 1991
Stossel TP: On the crawling of cells. Science 260: 1086–1093, 1993
Cross M, Dexter TM: Growth factors in development, transformation, and tumorgenicity. Cell 64: 271–280, 1991
Kurachi H, Morishige K, Amemiya K, Adichi H, Hirota K, Miyake A, Tanizawa O: Importance of transforming growth factor (alpha)/epidermal growth factor receptor autocrin growth mechanism in an ovarian cancer cell linein vivo. Cancer Res 51: 5956–5959, 1991
Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Doge R, Clarke-Pearson DL, Marks P, McKenzie S, Yin S, Bast RC: Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50: 4087–4091, 1990
Godwin AK, Hamilton TC, Knudson AG: Oncogenes and antioncogenes. Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology. J.B. Lippincott Company, Philadelphia, 1992, pp 87–116
DiFiore PP, Segatto O, Taylor WG, Aaronson SA, Pierce JH: EGF erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science 248: 79–83, 1990
Wahl MI, Nishibe S, Suh P-G, Rhe SG, Carpenter G: Epidermal growth factor stimulates tyrosine phosphorolation of phospholipase C-II independently of receptor internalization and extracellular calcium. Proc Natl Acad Sci USA 86: 1568–1572, 1989
Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238–1243, 1988
Marco ED, Pierce JH, Knicley CL: Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the ratneu gene. Mol Cell Biol 10: 3247-3252
Chapron Y, Cochet C, Crouzy S, Jullien T, Keramidas M, Verdetti J: Tyrosine protein kinase activity of the EGF receptor is required to induce activation of receptor-operated calcium channels. Biochem Biophys Res Commun 158: 527–533, 1989
Nishibe S, Wahl M, Hermandez-Sotomayor SMT, Tonks NK, Rhee SG, Carpenter G: Increase of the catalitic activity of phospholipase C-γ1 by tyrosine phosphorolation: Science 250: 1253–1256, 1990
Yang L, Camoratto AM, Baffy G, Raj S, Manning DR, Williamson JR: Epidermal growth factor-mediated signaling of Gi-protein to activation of phospholipases in rat-cultured hepatocytes. J Biol Chem 268: 3739–3746, 1993
Kadowaki T, Koyasu S, Nishida E, Tobe K, Izumi T, Takaku F, Sakai H, Yahara I, Kasuga M: Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor I, and epidermal growth factor in an intact cell. J Biol Chem 262: 7342–7350, 1987
Kojima I, Kitaoka M, Ogata E: Insulin like growth factor 1 stimulates diacylglycerol production via multiple pathways in Balb/c3T3 cells. J Biol Chem 265: 16846–16850, 1990
Kojima I, Mogami H, Shibata H, Ogata E: Role of calcium entry and protein kinase C in the progression activity of insulin-like growth factor-I in balb/c3T3 cells. J Biol Chem 268: 10003–10006, 1993
Egan SE, Wright JA, Jarolim L, Yanagihara K, Bassin RH, Greenberg AH: Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238: 202–205, 1987
Blay J, Brown KD: Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J Cell Physiol 124, 1985
Stracke ML, Kohn EC, Aznnavoorian SA, Wilson LL, Salomon D, Krutzsch HC, Liotta LA: Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem Biophys Res Commun 153: 1076–1083, 1988
Hari J, Pierce SB, Morgan DO, Sara V, Smith MC, Roth R: The receptor for insulin-like growth factor II mediates an insulin-like response. EMBO J 6: 3367–3371, 1987
Tally M, Li CH, Hall K: IGF-2 stimulated growth mediated by the somatomedin type 2 receptor. Biochem Biophys Res Commun 148: 811–816, 1987
Kohn EC, Liotta LA: L651582: A novel antiproliferative and antimetastasis agent. J Nat Cancer Inst 82: 54–60, 1990
Felder CC, Ma AL, Liotta LA, Kohn EC: The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J Pharm Exp Ther 257: 967–971, 1991
Kohn EC, Sandeen MA, Liotta LA:In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate and inositol phosphates. Cancer Res 52: 3208–3212, 1992
Pozzatti R, Muschel R, Williams J, Padmanabhan R, Howard B, Liotta L, Khoury G: Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 232: 223–227, 1986
Bonner TI, Young AC, Brann MR, Buckley NJ: Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1: 403–410, 1988
Jones SVP, Murphy TJ, Brann MR: Physiological comparison of cloned muscarinic receptor subtypes expressed in CHO cells. Trends in Pharm Sci 10: 116 (abstract 72), 1989
Gusovsky F, Lueders JE, Kohn EC, Felder CC: Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-γ. J Biol Chem 268: 7768–7772, 1993
Felder CC, MacArthur L, Ma AL, Gusovsky F, Kohn EC: Tumor-suppressor function of muscarinic acetylcholine receptors is associated with activation of receptor-operated calcium influx. Proc Natl Acad Sci USA 90: 1706–1710, 1993
Holmes KA, Chaffins S, Osborn BL, Liotta LA, Kohn EC: Quantitation of human plasma levels of the anticancer agent carboxyamidotriazole by high-performance liquid chromatography. J Chromatogr 613: 317–325, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cole, K., Kohn, E. Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metast Rev 13, 31–44 (1994). https://doi.org/10.1007/BF00690417
Issue Date:
DOI: https://doi.org/10.1007/BF00690417